搜尋
111 Inc
YI添加自選
4.130USD
-0.110-2.55%
收盤 07/02, 13:00（美東）報價延遲15分鐘
36.33M總市值
虧損本益比TTM
關鍵數據
4.230今開
4.280最高
4.92K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.01%換手率
4.140昨收
4.130最低
7.64K成交額
虧損本益比靜
-1.97市淨率
0.00%股息率 TTM
-0.90%ROA
11.17052週最高
0.16量比
-64.74M淨利潤
51.97M總股本
-0.1091每股盈餘TTM
0.62Beta
--ROE
2.48052週最低
3.62%振幅
5.33%毛利率
36.33M總市值
-4.06回報/風險
5.25%風險率
TradingKey 111 Inc股票評分
單位: USD 更新時間: 2026-07-02操作建議
111 Inc當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在藥品行業排名118/157位。機構持股佔比非常高，中期看，股價處於下降通道。近一個月，市場表現較差，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
111 Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
111 Inc亮點
亮點風險
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
估值低估
公司最新PE估值-37.85，處於3年歷史低位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉0.00股
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
111 Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
111 Inc簡介
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
公司代碼YI
公司111 Inc
CEOLiu (Junling)
網址http://corporate.111.com.cn/
相關品種
+1.62%
+3.50%
+3.96%
+3.72%
+3.31%
+6.14%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%熱門品種
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
常見問題
111 Inc(YI)的當前股價是多少？
111 Inc(YI)的當前股價是 4.13。
111 Inc 的股票代碼是什麼？
111 Inc的股票代碼是YI。
111 Inc股票的52週最高點是多少？
111 Inc股票的52週最高點是11.17。
111 Inc股票的52週最低點是多少？
111 Inc股票的52週最低點是2.48。
111 Inc的市值是多少？
111 Inc的市值是214.63M。
111 Inc(YI)股票的每股收益（EPS TTM）是多少
111 Inc(YI)股票的每股收益（EPS TTM）是-1.09。